Back to search
FDAFDA · Food and drugs·Recall number Z-1901-2024

smith&nephew OXINIUM Femoral Head 12/14 Taper, REF 71343204, 32 MM OD +4, Sterile; and smith&nephew, 12/14 Taper, REF 71343604, 36 MM M / +4

Published June 5, 2024 · Recall initiated: April 24, 2024

Summary

FDA records medical device Class II recall Z-1901-2024, published June 5, 2024 and initiated April 24, 2024. Recalling firm: Smith & Nephew Inc; Status: Ongoing; Reported quantity: 23 packages; Lot: REF 71343204 - Batch #23FM03219, Exp. June 2033; REF 71343604 - Batch 23FM04184, Exp. June 2033. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Packaging contained the incorrect size of femoral head from what was displayed on the label.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Smith & Nephew Inc
Distributor
International distribution to the countries of Australia, Germany, Japan, Portugal, and United Kingdom.
Lot
REF 71343204 - Batch #23FM03219, Exp. June 2033; REF 71343604 - Batch 23FM04184, Exp. June 2033.
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was smith&nephew OXINIUM Femoral Head 12/14 Taper, REF 71343204, 32 MM OD +4, Sterile; and smith&nephew, 12/14 Taper, REF 71343604, 36 MM M / +4 recalled?

Yes. FDA published recall Z-1901-2024 on June 5, 2024. Reported hazard: Packaging contained the incorrect size of femoral head from what was displayed on the label.

What should I do if I have this product?

Voluntary: Firm initiated · Letter